Oxford MEStar Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 3
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $6.64M
Latest Deal Amount
  • Investors
  • 4

Oxford MEStar General Information


Provider of bioengineering products and services intended to serve the translational and regenerative medicine industry. The company's products offer to scale up human cells, stem cell processing, manufacture of engineered tissues and cellular bioproducts and possess technical expertise in bioprocessing, bioengineering, and bio-manufacturing thereby developing technologies for tissue engineering and stem cell therapy, enabling clients to get access to 3D bioprinting, in-vitro diagnostic development, and other bio-engineering alternatives.

Contact Information

Formerly Known As
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • Centre for Innovation & Enterprise
  • Begbroke Science Park
  • Oxford OX5 1PF
  • England, United Kingdom
+44 01865 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford MEStar Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 21-Dec-2017 $6.64M 00.000 Completed Generating Revenue
3. Early Stage VC 30-Aug-2016 00000 00.000 00.000 Completed Generating Revenue
2. Early Stage VC 16-Dec-2014 $2.12M $3.73M 00.000 Completed Generating Revenue
1. Early Stage VC 01-Dec-2013 $1.61M $1.61M 00.000 Completed Startup
To view Oxford MEStar’s complete valuation and funding history, request access »

Oxford MEStar Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000 00.000000 00000.00 00000.00 00 00000.00 00.000
Ordinary 000 00.000000 00000.00 00000.00 00 00000.00 00.000
Ordinary 197 $0.013086 $1660.64 $1660.64 1x $1660.64 7.66%
Ordinary 275 $0.013086 $1665.47 $1665.47 1x $1665.47 10.69%
To view Oxford MEStar’s complete cap table history, request access »

Oxford MEStar Patents

Oxford MEStar Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-2591495-A Cytometry flow cell, system and method Pending 30-Jan-2020 000000000 0
US-20170007406-A1 Surgical implants Granted 10-Jul-2015 00000000 0
US-9579204-B2 Surgical implants Active 10-Jul-2015 00000000
US-20160047824-A1 Personal test device Abandoned 12-Nov-2012 0000000000
GB-201220350-D0 Personal test device Ceased 12-Nov-2012 G01N33/726
To view Oxford MEStar’s complete patent history, request access »

Oxford MEStar Executive Team (8)

Name Title Board Seat Contact Info
Robert Wang Ph.D Managing Director
Zhanfeng Cui Ph.D Founder & Chairman
Hong Chang Ph.D Head of China Collaboration
You’re viewing 3 of 8 executive team members. Get the full list »

Oxford MEStar Board Members (4)

Name Representing Role Since
Liwen Hu Self Board Member 000 0000
Zhanfeng Cui Ph.D Oxford MEStar Founder & Chairman 000 0000
You’re viewing 2 of 4 board members. Get the full list »

Oxford MEStar Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oxford MEStar Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Biotechnology and Biological Science Research Council Limited Partner 000 0000 000000 0
European Union Government 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
Oxford Spin-out Equity Management Venture Capital Minority 000 0000 000000 0
To view Oxford MEStar’s complete investors history, request access »